POS-467 RENAL AND HEPATIC OUTCOMES AFTER REMDESIVIR THERAPY IN COVID-19 POSITIVE PATIENTS WITH RENAL DYSFUNCTION AT BASELINE OR AFTER STARTING THERAPY
Autor: | AHMAD, S., Bhasin, N., Sinha, S., Sayed, S.A., Bansode, J., Swami, R., Mehta, K. |
---|---|
Zdroj: | In Kidney International Reports April 2021 6(4) Supplement:S203-S203 |
Databáze: | ScienceDirect |
Externí odkaz: |